SV2011003962A - Compuestos etanaminicos y su uso para tratar la depresion - Google Patents

Compuestos etanaminicos y su uso para tratar la depresion

Info

Publication number
SV2011003962A
SV2011003962A SV2011003962A SV2011003962A SV2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A
Authority
SV
El Salvador
Prior art keywords
ethanaminal
compounds
treat depression
piridin
amina
Prior art date
Application number
SV2011003962A
Other languages
English (en)
Spanish (es)
Inventor
Micahel Balestra
Peter Bernstein
Glen E Ernst
William Frietze
John P Mccauley
David Nugiel
Lihong Shen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42288011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2011003962(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SV2011003962A publication Critical patent/SV2011003962A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
SV2011003962A 2008-12-24 2011-06-24 Compuestos etanaminicos y su uso para tratar la depresion SV2011003962A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14067308P 2008-12-24 2008-12-24

Publications (1)

Publication Number Publication Date
SV2011003962A true SV2011003962A (es) 2012-01-06

Family

ID=42288011

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2011003962A SV2011003962A (es) 2008-12-24 2011-06-24 Compuestos etanaminicos y su uso para tratar la depresion

Country Status (31)

Country Link
US (4) US8013165B2 (enExample)
EP (2) EP2610246A1 (enExample)
JP (1) JP5491524B2 (enExample)
KR (1) KR20110097996A (enExample)
CN (1) CN102333762B (enExample)
AR (1) AR074981A1 (enExample)
AU (1) AU2009330745B2 (enExample)
BR (1) BRPI0923476A2 (enExample)
CA (1) CA2748235A1 (enExample)
CL (1) CL2011001590A1 (enExample)
CO (1) CO6450688A2 (enExample)
CR (1) CR20110365A (enExample)
CU (1) CU24017B1 (enExample)
DO (1) DOP2011000205A (enExample)
EA (1) EA201190064A1 (enExample)
EC (1) ECSP11011161A (enExample)
GT (1) GT201100186A (enExample)
HN (1) HN2011001773A (enExample)
IL (1) IL213518A0 (enExample)
MX (1) MX2011006680A (enExample)
NI (1) NI201100131A (enExample)
NZ (1) NZ593282A (enExample)
PE (1) PE20120249A1 (enExample)
SA (1) SA109310013B1 (enExample)
SG (2) SG171928A1 (enExample)
SV (1) SV2011003962A (enExample)
TW (1) TWI442922B (enExample)
UA (1) UA106056C2 (enExample)
UY (1) UY32360A (enExample)
WO (1) WO2010074647A1 (enExample)
ZA (1) ZA201105441B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201190064A1 (ru) * 2008-12-24 2012-02-28 Астразенека Аб Соединения этанамина и их применение для лечения депрессии
CN112279843B (zh) * 2020-11-24 2023-05-16 深圳市第二人民医院(深圳市转化医学研究院) 一种具有抗抑郁活性的含氮杂环化合物
CN112250676B (zh) * 2020-11-24 2023-05-16 深圳市第二人民医院(深圳市转化医学研究院) 一种具有抗抑郁活性的含氧杂环化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) * 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
GB1427026A (en) 1972-11-20 1976-03-03 Ici Ltd Synthetic film materials
JPS5756474B2 (enExample) 1973-05-26 1982-11-30
US5455259A (en) * 1987-02-06 1995-10-03 Fisons Corporation Compounds for the treatment of neurodegenerative disorders
GB9320273D0 (en) 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
EP0648489A1 (en) 1988-08-12 1995-04-19 Fisons Corporation Arylalkylamides having neuroprotective properties
JP2514855B2 (ja) 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
DK0612314T3 (da) * 1991-10-30 2000-05-29 Astra Ab 2-pyrazinylethylaminderivater og deres anvendelse som lægemidler
EP0633879B1 (en) * 1992-04-03 1998-03-11 Astra Aktiebolag Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
PL192561B1 (pl) * 1996-04-19 2006-11-30 Akzo Nobel Nv Podstawione benzyloaminy, ich zastosowanie i kompozycja farmaceutyczna
EP0869122B1 (en) 1997-03-31 2002-12-04 Korea Research Institute Of Chemical Technology Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
SE9901077D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901340D0 (sv) * 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
EA201190064A1 (ru) * 2008-12-24 2012-02-28 Астразенека Аб Соединения этанамина и их применение для лечения депрессии

Also Published As

Publication number Publication date
SG192510A1 (en) 2013-08-30
UA106056C2 (uk) 2014-07-25
SG171928A1 (en) 2011-07-28
EP2610246A1 (en) 2013-07-03
ZA201105441B (en) 2012-03-28
US20100179199A1 (en) 2010-07-15
US20120115913A1 (en) 2012-05-10
CO6450688A2 (es) 2012-05-31
AU2009330745A1 (en) 2011-08-04
CN102333762A (zh) 2012-01-25
EP2391606A1 (en) 2011-12-07
TW201028149A (en) 2010-08-01
CA2748235A1 (en) 2010-07-01
EP2391606A4 (en) 2012-06-13
CU24017B1 (es) 2014-07-30
AU2009330745B2 (en) 2012-04-05
BRPI0923476A2 (pt) 2016-01-19
US20130137731A1 (en) 2013-05-30
US8013165B2 (en) 2011-09-06
ECSP11011161A (es) 2011-07-29
JP2012513993A (ja) 2012-06-21
GT201100186A (es) 2013-10-08
NI201100131A (es) 2012-03-19
US20120277272A1 (en) 2012-11-01
CR20110365A (es) 2011-08-09
MX2011006680A (es) 2011-07-12
SA109310013B1 (ar) 2013-07-28
CL2011001590A1 (es) 2012-06-22
JP5491524B2 (ja) 2014-05-14
CU20110141A7 (es) 2012-01-31
US9035065B2 (en) 2015-05-19
KR20110097996A (ko) 2011-08-31
UY32360A (es) 2010-07-30
IL213518A0 (en) 2011-07-31
EA201190064A1 (ru) 2012-02-28
PE20120249A1 (es) 2012-04-19
WO2010074647A1 (en) 2010-07-01
TWI442922B (zh) 2014-07-01
DOP2011000205A (es) 2011-07-15
NZ593282A (en) 2013-06-28
AR074981A1 (es) 2011-03-02
CN102333762B (zh) 2014-06-11
HN2011001773A (es) 2014-08-18

Similar Documents

Publication Publication Date Title
CL2009000064S1 (es) Mango para maquina de afeitar.
CL2009001452S1 (es) Pieza agarre cabezal de cuchillas.
CL2009001263S1 (es) Maquina de afeitar.
CL2009001380S1 (es) Mango de maquina de afeitar.
SV2010003593A (es) Nuevos herbicidas
CR11776A (es) Inhibidores de bace
CL2009002072S1 (es) Mango para maquina de afeitar.
DK2338116T3 (da) Dokumentbaserede arbejdsgange
CL2011000481S1 (es) Aplicador para cuidado oral.
IT1394472B1 (it) Tavolo per riunioni.
BRPI0921950A2 (pt) suporte para ferramentas
CL2009001363S1 (es) Pieza para maquina de afeitar.
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
SMAP201000116A (it) Inibitori di diacetilasi B a base di idrossamato.
CU20130044A7 (es) Proceso para la preparación de inhibidores de pan-cdk de fórmula (i), e intermediarios de la preparación
CL2009001235A1 (es) Compuestos derivados 4-(3-alquilsulfinilbenzoil)pirazoles, composiciones herbicidas que los contine, procedimiento para reprimir plantas indeseadas, uso dichos compuestos y compuestos intermediarios.
ES2572368T3 (es) Tratamiento de la artrosis
SV2011003962A (es) Compuestos etanaminicos y su uso para tratar la depresion
CL2008001014A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol.
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
PA8851701A1 (es) Tratamiento para la glomerulonefritis
UY34033A (es) ?nuevos inhibidores de quinasa?.
ES1069000Y (es) Plantilla ergonomica para calzados
EE00857U1 (et) Teisaldatav teabe esitamise vahend
CL2008003510S1 (es) Placa para tensionar cordel.